Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLA2G2C | Q5R387 | 4/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | CES2 | O00748 | 1/20 | 0.42 |
| ▸ | ATM | Q13315 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | FAAH | O00519 | 1/20 | 0.36 |
| ▸ | USP2 | O75604 | 1/20 | 0.36 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.36 |
| ▸ | ESR1 | P03372 | 1/20 | 0.36 |
| ▸ | NAAA | Q02083 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5009224 | 0.95 | PLA2G2C (0.50) | PLA2G2CCES2FAAHUSP2NAAA | |
| SCHEMBL5009150 | 0.86 | HSD17B10 (0.41) | PLA2G2CALDH1A1CES2TSHRFAAH | |
| SCHEMBL6115912 | 0.84 | ALDH1A1 (0.47) | ALDH1A1CES2ATMTSHRHPGD | |
| SCHEMBL6116720 | 0.82 | ALDH1A1 (0.45) | ALDH1A1CES2ATMTSHRHPGD | |
| SCHEMBL6116580 | 0.82 | ALDH1A1 (0.45) | ALDH1A1CES2ATMTSHRHPGD | |
| SCHEMBL13994931 | 0.82 | PLA2G2C (0.38) | PLA2G2CCES2ATMTSHRFAAH | |
| SCHEMBL6117438 | 0.81 | ALDH1A1 (0.44) | ALDH1A1CES2ATMTSHRHPGD | |
| SCHEMBL6116559 | 0.79 | MAPT (0.46) | ALDH1A1CES2ATMTSHRHPGD | |
| SCHEMBL20995906 | 0.79 | ALDH1A1 (0.42) | PLA2G2CALDH1A1ATMTSHRHPGD | |
| SCHEMBL6117225 | 0.79 | MAPT (0.46) | ALDH1A1CES2ATMTSHRHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1637514-B1 | METHOD FOR PRODUCING FLUORINE-CONTAINING ACRYLATE | TOSOH F TECH INC (JP) | 2014-05-07 | — | — | EP | disclosed |
| US-7470808-B2 | Method for producing fluorine-containing acrylate | TOSOH F-TECH, INC. (JP) | 2008-12-30 | — | — | US | disclosed |
| US-7470808-B2 | Method for producing fluorine-containing acrylate | TOSOH F-TECH, INC. (JP) | 2008-12-30 | — | — | US | disclosed |
| US-20060122423-A1 | Method for producing fluorine-containing acrylate | SAGAMI CHEMICAL RESEARCH CENTER (JP) | 2006-06-08 | — | — | US | disclosed |
| EP-1637514-A1 | METHOD FOR PRODUCING FLUORINE-CONTAINING ACRYLATE | Tosoh F-Tech, Inc. (JP) | 2006-03-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060122423-A1 | Method for producing fluorine-containing acrylate | AFF4, CBR1, AFF1 | PLA2G2C 3094/4885ALDH1A1 174/4885CES2 185/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.